試す 金 - 無料
A Vaccine for all Occasions
Newsweek
|May 21 - 28, 2021 (Double Issue)
Scientists are developing a “universal vaccine” that would protect against anything the coronavirus can throw at us and maybe even the common cold.
It took Barney Graham, Jason Mclellan and their collaborators just a weekend in January 2020 to design a novel vaccine they believed would be capable of protecting people against COVID-19. Their design formed the basis for the vaccines that Moderna, Pfizer and others would eventually use to inoculate millions of Americans a little more than a year later, a pace of development unprecedented in the annals of modern medicine.
By then, however, the two pioneering virologists were already thinking about future pandemics— and how they might get ahead of them.
Graham and McLellan are part of a corps of researchers hoping to take the technology they used on COVID-19 vaccines and apply them to an even more futuristic creation: an arsenal of off-the-shelf premade vaccines that could be easily modified to attack new pathogens as they arise—a kind of “pan” or “universal” coronavirus vaccine capable of protecting against many different strains of the virus at the same time.
Even as scientists race to develop booster shots and tweak existing vaccines to work against new variants to SARS2, they’re looking ahead to future pandemics caused by entirely new pathogens from the same coronavirus family, one of just 26 known to infect humans. But SARS-CoV-2 is the third novel, deadly coronavirus to cross over from animals to humans in the last 20 years, and many scientists warn more will inevitably follow. Even though a “universal” vaccine that can protect against any new coronavirus that nature throws at us probably won’t be available this year or next, development has become a high priority.
このストーリーは、Newsweek の May 21 - 28, 2021 (Double Issue) 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Newsweek からのその他のストーリー
Newsweek US
WILL SHARPE
The actor has been on a roll since White Lotus, and his latest role as Wolfgang Amadeus Mozart in the Starz limited series Amadeus may be his “most exciting challenge” yet
2 mins
July 03, 2026
Newsweek US
From Root to Tree
As executive producer, Brooke Shields had her hand in everything on You're Killing Me
1 min
July 03, 2026
Newsweek US
SHINMEI Strengthens Japan's Food Security Globally
SHINMEI Holdings is linking overseas demand for Japanese food with domestic agricultural renewal, using innovation, exports and producer support to strengthen Japan's food security.
4 mins
July 03, 2026
Newsweek US
UNCOMMON KNOWLEDGE Emperor's New Clothes
President Donald Trump marked his 80th birthday by turning the White House into a fight venue-prompting familiar Roman emperor comparisons.
1 mins
July 03, 2026
Newsweek US
From Shinkansen Icon to Global Sensation: Bringing Japan’s Premium Ice Cream Experience to the World
Sujahta Meiraku aims to export the premium quality and unique experience of its signature “Shinkansen ice cream” through tourism-driven retail and experiential dessert concepts worldwide.
4 mins
July 03, 2026
Newsweek US
A Victory off the Pitch
China didn't qualify for the FIFA World Cup, but that hasn't stopped its brands performing.
1 min
July 03, 2026
Newsweek US
Socials Win Clicks as Trust Takes a Hit
The numbers tell a striking story-and hint at a deeper shift in how people relate to news.
1 min
July 03, 2026
Newsweek US
ANSWERING THE CALL
With theatrical rom-coms nearly extinct, Netflix is finding success building the genre’s new home
2 mins
July 03, 2026
Newsweek US
The Feed Doesn't Follow House Rules
A parent can pick up their kid's phone and find an impossible assignment waiting: monitor every app, feed, stranger, algorithmic nudge, sleepless doomscroll.
1 min
July 03, 2026
Newsweek US
RUFFLED FEATHERS
A $1.4 billion Jared Kushner-backed resort is putting Albania’s EU ambitions, its rule of law and its flamingos on the line
5 mins
July 03, 2026
Translate
Change font size
